Citadel Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-137,557
| Closed | -$1.93M | – | 4512 |
|
|
2017
Q1 | $1.93M | Buy |
137,557
+100,513
| +271% | +$1.41M | ﹤0.01% | 1706 |
|
|
2016
Q4 | $695K | Buy |
+37,044
| New | +$695K | ﹤0.01% | 2238 |
|
|
2016
Q3 | – | Sell |
-79,516
| Closed | -$1.07M | – | 4391 |
|
|
2016
Q2 | $1.07M | Buy |
79,516
+56,182
| +241% | +$755K | ﹤0.01% | 1789 |
|
|
2016
Q1 | $357K | Sell |
23,334
-10,317
| -31% | -$158K | ﹤0.01% | 2413 |
|
|
2015
Q4 | $668K | Buy |
33,651
+17,097
| +103% | +$339K | ﹤0.01% | 2226 |
|
|
2015
Q3 | $288K | Buy |
16,554
+7,048
| +74% | +$123K | ﹤0.01% | 2967 |
|
|
2015
Q2 | $192K | Buy |
9,506
+5,676
| +148% | +$115K | ﹤0.01% | 3059 |
|
|
2015
Q1 | $67K | Buy |
3,830
+3,044
| +387% | +$53.3K | ﹤0.01% | 3339 |
|
|
2014
Q4 | $13K | Sell |
786
-7,586
| -91% | -$125K | ﹤0.01% | 3734 |
|
|
2014
Q3 | $185K | Sell |
8,372
-11
| -0.1% | -$243 | ﹤0.01% | 2911 |
|
|
2014
Q2 | $169K | Sell |
8,383
-6,818
| -45% | -$137K | ﹤0.01% | 2868 |
|
|
2014
Q1 | $283K | Sell |
15,201
-12,105
| -44% | -$225K | ﹤0.01% | 2648 |
|
|
2013
Q4 | $275K | Sell |
27,306
-29,251
| -52% | -$295K | ﹤0.01% | 2346 |
|
|
2013
Q3 | $729K | Sell |
56,557
-122,861
| -68% | -$1.58M | ﹤0.01% | 1718 |
|
|
2013
Q2 | $2.13M | Buy |
+179,418
| New | +$2.13M | ﹤0.01% | 1379 |
|